Why J&J Throwing Out 15 Million COVID-19 Vaccine Doses Shouldn’t Scare You

Human errors at a manufacturing plant forced Johnson & Johnson to throw out 15 million doses of its COVID-19 vaccine – enough to vaccinate 7% of the U.S. adult population. 

The New York Times, which first reported the loss on March 31, 2021, called it "a major embarrassment" for the vaccine-maker and its subcontractor, Emergent BioSolutions.

But while errors with an impact of that magnitude sound shocking, they're also a reminder that the U.S. vaccine manufacturing process has strict quality control measures designed to catch these problems before they reach the public.

Vaccine manufacturing is complex, with many potential points for errors. As an expert in health care operations and the COVID-19 vaccine rollout, I closely follow vaccine manufacturing and approval processes. The multiple layers of quality checks by the producer and external inspectors throughout the process are essential to protect public health.

Checking the vaccines, and checking them again

After authorizing a vaccine, the U.S. Food and Drug Administration must approve and regularly inspect each vaccine manufacturing facility. 

Before each batch of vaccines is released by the FDA, it undergoes rigorous and extensive testing to ensure vaccine safety. In the case of COVID-19 vaccines, manufacturers are required to submit the results of each quality control test for each batch of vaccines 48 hours prior to its distribution. This stringent quality control process has led to what the FDA describes as the safest vaccine supply in U.S. history.

The quality control process is also how Johnson & Johnson discovered defects within the batch of 15 million doses at the Emergent BioSolutions facility. 

The Baltimore plant was one of several contracted by the federal government in 2020 to help vaccine-makers ramp up production. The facility was still awaiting authorization from the FDA to deliver the vaccines for U.S. use when the problems were discovered. As standard practice, Johnson & Johnson said it had specialists at the facility to check safety and quality. The Washington Post reported that workers at the facility in late February mixed up the ingredients for the AstraZeneca and Johnson & Johnson vaccines both being produced there, throwing the entire batch into question. The FDA had previously flagged quality control concerns at Emergent's Baltimore plant related to its testing of a potential treatment for anthrax, according to the records obtained by the Associated Press. 

All vaccine manufacturing plants – domestic and international – require authorization from the FDA before they can supply vaccines to the U.S. population. The Johnson & Johnson vaccines currently used in the U.S. were manufactured in Johnson & Johnson's own facility in the Netherlands. 

The U.S. government's Operation Warp Speed has also been involved in quality control. At one point, it deployed 16 Department of Defense personnel to two manufacturing sites to fill gaps in the quality control workforce so production could continue.

After vaccines have been distributed, the Centers for Disease Control and Prevention continues to monitor for any problems in patients.

[Get the best of The Conversation, every weekend. Sign up for our weekly newsletter.]

How much time goes into quality checks?

The U.S. learned years ago how crucial quality control checks and independent verification are for vaccine safety. In 1955, the polio vaccine rollout led to 40,000 vaccine-induced polio infections.

Flu vaccine-maker Sanofi says it now spends about 70% of its production time on quality checks, and its vaccines are checked again by health officials once they're shipped from the facility.

The new mRNA technology used by COVID-19 vaccine-makers Moderna and Pfizer is somewhat less challenging because it doesn't involve live virus, as traditional flu vaccines do. Pfizer says it spends more than half of its production time on assuring the quality of each batch. 

Manufacturing improvements are also crucial

Manufacturing process improvement is just as important as thorough quality testing, because errors do happen.

In 2020, AstraZeneca revealed that a manufacturing error led to one-and-a-half – instead of two – doses of its vaccine being given to nearly 3,000 study patients. That error clouded its study results and delayed the U.S. approval process by months.

The Biden administration has asked Johnson & Johnson to step up its supervision of Emergent's production process. 

The incident shows that the industry has work to do to minimize manufacturing errors. Yet, I would argue that the public has every reason to remain confident in the rigorous quality control process that prevents bad vaccines from circulating and ensures vaccine safety.


Tinglong Dai Johns Hopkins University School of Nursing

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)

Tinglong Dai, Johns Hopkins University School of Nursing


This article is republished from The Conversation under a Creative Commons license. Read the original article here: https://theconversation.com/why-johnson-and-johnson-throwing-out-15-million-covid-19-vaccine-doses-shouldnt-scare-you-158300.


CAPE CANAVERAL, Fla. (AP) — New research indicates the sun’s magnetic field originates much closer to the surface than previously thought, a finding that could help predict periods of extreme solar storms like the ones that slammed Earth earlier this month.

Top Stories


A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.


2 Germans, a Spaniard and a Senegalese Killed in Building Collapse in Spain’s Mallorca Island

MADRID (AP) — Spain's National Police on Friday gave details on four people killed when a building housing a bar and restaurant club collapsed on the island of Mallorca.

NEW YORK – The New York Times has reported that “an aide to Mayor Eric Adams who served as his longtime liaison to the Turkish community has turned against him and is cooperating with the corruption investigation into Mr.

BOSTON – Crowds flocked to the Greek Festival of the St.

The news about air travel lately hasn't been pleasant.

Beyond the issues in Crete and our own in America, as we wrote in our ‘Analysis’ in last week’s edition, Patriarch Bartholomew has unfortunately ensnared himself in problems with the majority of local Orthodox Churches worldwide, with few exceptions such as those of Greece, Alexandria, and Cyprus, due to the granting of Autocephaly to Ukraine, which has proven to be ill-timed and ill-suited.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.